Pancreatic Cancer Research

ResearcherManipal Academy of Higher EducationNo recent work listed

Biswajit Das

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5657-5626; OpenAlex author ID A5019372914. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: 2 papers

Papers 4

  1. MicroRNA-217 modulates pancreatic cancer progression via targeting ATAD2. First author DOI 10.1016/j.lfs.2022.120592↗
  2. Fluvastatin sensitizes pancreatic cancer cells toward radiation therapy and suppresses radiation- and/or TGF-β-induced tumor-associated fibrosis. First author DOI 10.1038/s41374-021-00690-7↗
  3. Functional and mechanistic studies reveal MAGEA3 as a pro-survival factor in pancreatic cancer cells. Co-author DOI 10.1186/s13046-019-1272-2↗
  4. Experimental models of pancreatic cancer desmoplasia. Co-author DOI 10.1038/labinvest.2017.127↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shantibhusan Senapati · 4 shared papers, 2018–2022 · strength 0.64
  2. Debasish Mohapatra · 2 shared papers, 2022 · strength 0.34
  3. Voddu Suresh · 2 shared papers, 2018–2022 · strength 0.25
  4. Madhuri Dutta · 1 shared paper, 2022 · strength 0.19
  5. Anasuya Roychowdhury · 1 shared paper, 2022 · strength 0.19
  6. Deepti Parida · 1 shared paper, 2022 · strength 0.16
  7. Aliva Prity Minz · 1 shared paper, 2022 · strength 0.16
  8. Sujit Suklabaidya · 1 shared paper, 2018 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.